Workflow
闰土股份(002440) - 2019 Q3 - 季度财报
RTGFRTGF(SZ:002440)2019-10-24 16:00

Financial Performance - Net profit attributable to shareholders decreased by 19.46% to CNY 250,055,065.37 for the reporting period[10]. - Operating revenue for the period was CNY 1,839,816,933.45, reflecting a growth of 12.08% year-on-year[10]. - Basic earnings per share decreased by 18.52% to CNY 0.22 for the reporting period[10]. - The weighted average return on equity was 3.04%, down by 1.19% compared to the previous year[10]. - The net profit after deducting non-recurring gains and losses was CNY 248,738,284.75, an increase of 0.78% year-on-year[10]. - The company reported a total comprehensive income of ¥239,700,973.37, down from ¥316,602,599.59 in the previous period[79]. - Net profit for the current period was ¥240,998,016.27, a decrease of 21.66% from ¥307,717,316.97 in the same period last year[75]. - The net profit for the period was 668,831,201.43, a decrease of 23% compared to 867,881,600.86 in the previous period[102]. Assets and Liabilities - Total assets increased by 4.49% to CNY 10,523,249,715.18 compared to the end of the previous year[10]. - The company's current assets totaled CNY 5,847,251,517.69, compared to CNY 5,454,136,059.01 at the end of December 2018, reflecting a growth of approximately 7.2%[55]. - Total liabilities stood at CNY 5,847,251,517.69, reflecting a stable financial position[55]. - Short-term borrowings surged to CNY 349,000,000.00 from CNY 60,000,000.00, indicating a significant increase of approximately 481.7%[55]. - The total equity attributable to shareholders increased from ¥7,966,086,891.47 to ¥8,482,254,432.58, representing a growth of approximately 6.5%[61]. - Total liabilities amounted to ¥1,859,769,433.18, with current liabilities at ¥1,831,493,770.65[128]. - The company's total equity reached ¥8,210,960,702.80, including ¥5,133,028,935.98 in undistributed profits[128]. Cash Flow - The net cash flow from operating activities was CNY 347,961,462.02, a decrease of 1.87% compared to the same period last year[10]. - The net cash flow from operating activities increased by 99.94% to ¥1,568,111,932.26, driven by higher cash receipts from sales compared to the previous year[27]. - The net cash flow from operating activities was CNY 820,637,952.55, a significant increase from CNY 247,707,002.94 in the previous period, representing a growth of approximately 230%[115]. - Total cash inflow from operating activities reached CNY 1,622,275,383.50, compared to CNY 1,117,313,017.24 in the prior period, marking an increase of about 45%[115]. - The company reported a cash and cash equivalents balance of CNY 359,038,897.26 at the end of the period, up from CNY 184,228,634.17, reflecting an increase of about 95%[118]. Investments - The company has invested ¥50,000,000 in Guobang Pharmaceutical Chemical Group, acquiring a 1.3158% equity stake[28]. - The company plans to invest in two funds, each with a target size of ¥200,000,000, to enhance its investment portfolio[28]. - The company reported a 140.99% increase in investment income to ¥14,850,136.38, resulting from higher returns from joint ventures and trust product investments[24]. - The company recorded an investment income of ¥14,850,136.38, significantly higher than ¥6,162,108.28 in the previous period, representing an increase of approximately 141.5%[89]. Shareholder Information - The total number of shareholders at the end of the reporting period was 49,022[14]. - The largest shareholder, Zhang Aijuan, holds 16.73% of the shares, totaling 192,454,893 shares[14]. Government Subsidies - The company reported a government subsidy of CNY 234,112,261.94 recognized in the current period[10]. - The company received government subsidies, leading to a 154.80% increase in non-operating income to ¥239,990,276.98[24]. Research and Development - Research and development expenses were ¥62,698,719.99, a decrease of 21.00% from ¥79,297,815.26 in the prior period[72]. - Research and development expenses for the current period were ¥165,796,022.37, down from ¥184,406,353.42, showing a decrease of about 10.0%[89]. Environmental and Safety Management - The company has actively implemented safety and environmental management measures in response to local government regulations following a major safety incident[31]. - The company’s subsidiaries, Jiangsu Mingsheng and Jiangsu Yuanzheng, temporarily halted production due to environmental inspections but have received government approval to resume operations[31].